Human Insulin: Clinical Trials

32 trials of Human Insulin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 3 not yet recruiting, 3 unknown, 1 active not recruiting. 9 Phase 4, 7 Not applicable, 5 Early Phase 1, 5 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 49Completed 7, Unknown 2
Not applicable7Completed 5, Active not recruiting 1, Unknown 1
Early Phase 15Not yet recruiting 2, Completed 1, Suspended 1, Withdrawn 1
Phase 15Completed 4, Terminated 1
Phase 24Completed 3, Not yet recruiting 1
Phase 33Completed 2, Not yet recruiting 1

Follow Human Insulin: new trials by email Literature Review of Human Insulin trials Research Report on Human Insulin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Response Study of Transdermal Human Insulin in Patients
Human Insulin, Finger-actuated, Metered Pump Sprayer - Glucose, High Blood
Phase 2 / Phase 3Not yet recruitingTransdermal Delivery Solutions Corp302027-09-022026-05-26
Peripheral Vascular Effects of Insulin in Obesity
human insulin - Obesity (BMI>30), Insulin Resistance
Early Phase 1Not yet recruitingUniversity of Missouri-Columbia642026-12-012026-10-15
Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity
human insulin - Obesity (BMI>30), Insulin Resistance
Early Phase 1Not yet recruitingUniversity of Missouri-Columbia642026-12-012026-10-15
Effect of Topical Insulin on Healing Rate of Pemphigus Lesions
insulin glargine, human insulin, 0.9% Normal Saline - Pemphigus Vulgaris, Skin Erosion
Phase 2CompletedAlexandria University202024-06-222026-03-10
Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation
Carbon dioxide breathing, Neurovascular Coupling, Human insulin - Healthy, Vasodilation
Early Phase 1SuspendedUniversity of Missouri-Columbia652021-12-012025-12-19
Insulin for Hyperglycemia in Stroke Trial
Analog Insulin, Human insulin - Hyperglycemia, Stroke, Acute
Phase 4CompletedNational Institute of Neurosciences and Hospital, Dhaka4522021-04-052021-12-06
Transdermal Insulin Response In Healthy Volunteers
Human insulin - Pharmacodynamic Response to Small Doses of Insulin
Early Phase 1CompletedTransdermal Delivery Solutions Corp72021-03-122023-10-23
Pupillography as Screening Tool for Brain Insulin Resistance
human insulin, placebo, Pupillography - Obesity
Not applicableCompletedUniversity Hospital Tuebingen222018-07-032019-01-10
HbA1c Variability in Type II Diabetes
Metformin, Gliclazide, Sitagliptin - Diabetes Mellitus Type 2
Not applicableActive not recruitingWeill Cornell Medical College in Qatar1502016-11-012025-07-20
Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
human insulin - Insulin Resistance
Not applicableCompletedUniversity Hospital Tuebingen212015-01-012016-01-08
A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue
Insulin Peglispro, Human Insulin - Diabetes Mellitus, Type 1
Phase 1CompletedEli Lilly and Company242014-04-012019-03-06
Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin Application
Human Insulin, Placebo - Obesity, Diabetes
Not applicableCompletedUniversity Hospital Tuebingen482013-02-012015-12-03
Molecular Regulation of Muscle Glucose Metabolism
U100 Humulin, Exercise - Obesity, Type 2 Diabetes Mellitus
Phase 1TerminatedMayo Clinic482012-04-012017-11-27
Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance
Human insulin - Type 2 Diabetes Mellitus
Phase 1CompletedMayo Clinic142012-03-012013-06-05
Effect of CSII and CGM on Progression of Late Diabetic Complications
Insulin pump therapy (CSII) plus continuous glucose monitoring (CGM), Multiple daily insulin injections (MDI) - Type 1 Diabetes Mellitus
Phase 4CompletedSteen Andersen602011-12-012015-01-14
Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use
nph insulin, human insulin, Insulin Glargine - Insulin-requiring Type 2 Diabetes Mellitus
Phase 4Unknownikfe-CRO GmbH602011-10-012011-12-29
Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) Kinetics
Glucose clamp - Obesity, Dyslipidemia
Not applicableCompletedUniversity of Aarhus242010-03-012011-06-17
Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in Paraguay
Basal Bolus (Glargine and Glulisine), Human Insulin - Hyperglycemia, Diabetes
Phase 4CompletedUniversidad Nacional de Asunción1342009-04-012014-10-30
Investigating the Accuracy of the Home Glucose Monitors in Hypoglycemia
Human insulin, Human Insulin - Hypoglycemia
Phase 4CompletedGulhane School of Medicine512008-12-012009-11-13
Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects
human insulin, insulin analogue - Diabetes, Diabetes Mellitus, Type 2
CompletedNovo Nordisk A/S48472008-12-012016-10-28

Showing 20 of 32. Sign in to see all of them.

Conditions studied

Diabetes Mellitus (12)  ·  Insulin Resistance (10)  ·  Obesity (8)  ·  Diabetes Mellitus, Type 1 (7)  ·  Diabetes Mellitus, Type 2 (7)  ·  Hyperglycemia (2)  ·  Hypoglycemia (2)  ·  Albuminuria (1)  ·  Aneurysm (1)  ·  Cognitive Dysfunction (1)  ·  Diabetes, Gestational (1)  ·  Dyslipidemias (1)  ·  Hyperinsulinism (1)  ·  Pemphigus (1)  ·  Primary Dysautonomias (1)

Sponsors

Novo Nordisk A/S (8)  ·  University Hospital Tuebingen (4)  ·  University of Missouri-Columbia (3)  ·  Mayo Clinic (2)  ·  Transdermal Delivery Solutions Corp (2)  ·  Alexandria University (1)  ·  Eli Lilly and Company (1)  ·  Gulhane School of Medicine (1)  ·  Heidelberg University (1)  ·  Hypoglycaemia Research Group (1)  ·  National Institute of Neurosciences and Hospital, Dhaka (1)  ·  Steen Andersen (1)  ·  Universidad Nacional de Asunción (1)  ·  University of Aarhus (1)  ·  University of Colorado, Denver (1)

Countries

Germany (9)  ·  United States (8)  ·  Denmark (5)  ·  Austria (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)  ·  Bangladesh (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Croatia (1)  ·  Egypt (1)  ·  Finland (1)  ·  France (1)

Top investigators

Andreas Fritsche, MD (1)  ·  Andreas Fritsche, Prof. Dr. (1)  ·  Birger Thorsteinsson, MD, DMSci (1)  ·  Carmen I Farid, MB BCh, MD (1)  ·  Chandan A.S. Alam, MD (1)  ·  Elvio Bueno, MD (1)  ·  Ezio Bonifacio, PhD (1)  ·  Georgeanna J Klingensmith, MD (1)  ·  Jacqueline K Limberg, Ph.D. (1)  ·  Katherine N Bachmann, MD (1)  ·  Lawrence J. Mandarino, PhD (1)

Results publications

PMID 12502678, PMID 17392539, PMID 17392541, PMID 17392542, PMID 17596485, PMID 17850471, PMID 17888133, PMID 17905178, PMID 18726086, PMID 19120432, PMID 19170163, PMID 19584889, PMID 20007944, PMID 20215476, PMID 23687948, PMID 25300286, PMID 25795413, PMID 25898052, PMID 26390102, PMID 28174292, PMID 31334795, PMID 32887707, PMID 33166419

NIH funding

R01DK047936 (1)